ASC - Fulfilment of all outstanding conditions precedent relating to the acquisitions of Remedica and Scitec ASCENDIS HEALTH LIMITED (Incorporated in the Republic of South Africa) (Registration number 2008/005856/06) ISIN: ZAE000185005 Share code: ASC (“Ascendis Health” or the “Company”) FULFILMENT OF ALL OUTSTANDING CONDITIONS PRECEDENT RELATING TO THE ACQUISITIONS OF REMEDICA AND SCITEC 1. INTRODUCTION Shareholders of Ascendis Health (“Shareholders”) are referred to the announcement released on the Stock Exchange News Service of the JSE Limited on 24 May 2016, wherein Shareholders were advised that Ascendis Health had entered into agreements to acquire, directly or indirectly, through two distinct and divisible transactions: - The entire issued share capital of Remedica Holdings Limited, a pharmaceutical company based in Cyprus (“Remedica Transaction”); and - The entire issued share capital of Scitec International S.à r.l., a European sports nutrition company (“Scitec Transaction”); and the circular to Shareholders dated 12 July 2016, setting out the details of the Remedica Transaction and the Scitec Transaction (together the “Transactions”), as well as a rights offer and a vendor consideration placing. 2. FULFILMENT OF ALL CONDITIONS PRECEDENT Shareholders are advised that all conditions precedent pertaining to the Transactions have now been fulfilled or waived, as the case may be, with the payment by Ascendis Health for the Transactions being concluded on 25 August 2016. As such the Transactions are officially unconditional and have been implemented as of 25 August 2016. 26 August 2016 Johannesburg Corporate Advisor Coast2Coast Capital Proprietary Limited Transaction Sponsor Absa Bank Limited (acting through its Corporate and Investment Bank division) Sponsor Investec Bank Limited Date: 26/08/2016 10:19:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.